Dr. Rany Aburashed, D.O., is the Corporate Chief Medical Officer and Chief of Sub-Specialty Services at Insight. He completed his undergraduate studies in psychology and world religion at Albion College, graduating with honors. He received the Michigan Medical Grant to attend Michigan State University’s College of Osteopathic Medicine, where he received his doctorate in 2006. After completing his neurology residency, Dr. Aburashed served as the chief resident at Michigan State University/Sparrow Hospital.
Dr. Rany Aburashed, D.O., is the Corporate Chief Medical Officer and Chief of Sub-Specialty Services at Insight. He completed his undergraduate studies in psychology and world religion at Albion College, graduating with honors. He received the Michigan Medical Grant to attend Michigan State University’s College of Osteopathic Medicine, where he received his doctorate in 2006. After completing his neurology residency, Dr. Aburashed served as the chief resident at Michigan State University/Sparrow Hospital.
The reviews listed below were collected independently of Insight Health through rater8. Each review represents an authentic and verified patient experience.
A friendly and very considerate about patient care and needs
Dr. Rany Aburashed, D.O., is the Corporate Chief Medical Officer and Chief of Sub-Specialty Services at Insight. Dr. Aburashed completed his undergraduate studies in psychology and world religion at Albion College, graduating with honors. He received the Michigan Medical Grant to attend Michigan State University’s College of Osteopathic Medicine, where he received his doctorate in 2006. After completing his neurology residency, Dr. Aburashed served as the chief resident at Michigan State University/Sparrow Hospital.
Following his education, Dr. Aburashed went on to be the founder of Memorial Healthcare’s Institute for Neurosciences and Multiple Sclerosis. Before joining Insight’s executive leadership team, Dr. Aburashed previously served as the Chair of Neurology and Chair of specialty services at Memorial Healthcare.
He has extensive research experience in the neuroimmunology space, serving as primary investigator on over 30 phase 1-4 clinical trials. In addition to this, he is best known for his work using single molecule array assay technology to assess protein biomarkers in multiple sclerosis patients. Dr. Aburashed’s primary research interest is in precision disease management using neurofilament light and biomarker profiles to better understand treatment effects in multiple sclerosis.
Dr. Aburashed has been featured on CNN, Nasdaq, Yahoo News, and multiple other news outlets regarding his clinical expertise and lectures both nationally and internationally on his work.
A friendly and very considerate about patient care and needs